# Metal–Organic Framework-Based Drug Delivery Systems for Cancer Therapy: A Review

## TL;DR

This paper reviews how metal-organic frameworks (MOFs) can be used to improve cancer drug delivery by offering high surface areas and tunable structures.

## Contribution

The paper provides a comprehensive review of MOF-based drug delivery systems, emphasizing their synthesis, drug-loading, and biomedical applications.

## Key findings

- MOFs have high surface areas and tunable structures suitable for drug delivery.
- Stimuli-responsive MOFs enhance cancer therapy effectiveness.
- MOFs offer biodegradable properties and controlled drug release.

## Abstract

Cancer remains one of the most significant global health challenges, with conventional treatments limited by side effects and resistance to drugs. The unique properties of metal–organic frameworks (MOFs), which offer high surface areas, tunable structures, and biodegradable properties, make them promising candidates for cancer therapy. This review focuses on MOF-based drug delivery systems for cancer treatment in biomedical applications. This article discusses various synthesis methods, drug-loading strategies, and cytotoxicity considerations. The relationship between the basic chemistry of MOFs and their biomedical applications is elucidated by how each feature directly affects MOF performance in cancer drug delivery. Therefore, this review is a practical and complete guide for researchers working to translate MOFs into effective cancer treatments. Moreover, the role of stimuli-responsive MOFs in cancer therapy is highlighted, along with recent studies demonstrating the effectiveness of MOF-based drug delivery systems. Overall, MOFs offer opportunities for advancing cancer treatment and controlled drug delivery.